Expression of gelatinase B in trachomatous conjunctivitis
Authors:
- Karel GeboesKGKarel Geboes
- Luc MissottenLMLuc Missotten
- Liesbet PaemenLPLiesbet Paemen
- Ghislain OpdenakkerGOGhislain Opdenakker
Open Access
- 1 January 2000
- journal article
- research article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 84 (1) , 85-91
Abstract
BACKGROUND/AIMS Gelatinase B is a matrix metalloproteinase involved in extracellular matrix (ECM) breakdown often associated with scarring and other pathological disorders. It was investigated whether gelatinase B is involved in the pathogenesis of ECM degradation associated with trachomatous conjunctivitis. METHODS Conjunctival biopsy specimens obtained from six patients with active trachoma, six patients with active vernal keratoconjunctivitis (VKC), and seven control subjects were studied. Immunohistochemical techniques and a specific monoclonal antibody against human gelatinase B were used, and a monoclonal antibody against macrophage CD68 to identify mononuclear cells with gelatinase B immunoreactivity. In addition, quantitative zymography was used to compare the activity of gelatinase B in conjunctival biopsy specimens from seven patients with active trachoma and seven control subjects. RESULTS Gelatinase B was detected by immunohistochemistry only in polymorphonuclear cells located in the vascular lumens in three normal conjunctival biopsy specimens. In all trachoma specimens and in five VKC specimens, gelatinase B was localised in monocyte/macrophage cells, positive for the CD68 marker, and in polymorphonuclear cells. The majority of the latter cell type was located in intravascular spaces. Compared with VKC specimens, trachoma specimens showed significantly more immunoreactive gelatinase B monocyte/macrophage cells (52.3 (21.9)v 8.2 (6.4); p v 6.3 (5.4); p = 0.013). Activated macrophages with giant cell morphology clearly stained with the gelatinase B specific monoclonal antibody were observed in trachoma specimens. Zymography revealed that gelatinase B levels in trachoma specimens were significantly higher than the levels found in normal conjunctiva (1739.6 (1078.3)v 609.3 (395.9) scanning units; p = 0.0127). CONCLUSIONS The increased activity of gelatinase B and numbers of inflammatory cells containing gelatinase B in trachoma specimens suggest that this enzyme plays a part in the pathogenesis of conjunctival scarring in trachoma.Keywords
This publication has 43 references indexed in Scilit:
- Collagen content and types in trachomatous conjunctivitisEye, 1998
- Immunopathogenesis of conjunctival scarring in trachomaEye, 1998
- In Situ Localization and Quantification of mRNA for 92-kD Type IV Collagenase and Its Inhibitor in Aneurysmal, Occlusive, and Normal AortaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Early changes in matrix metalloproteinases and inhibitors after in vitro laser treatment to the trabecular meshworkCurrent Eye Research, 1995
- Lipopolysaccharide in cells infected by Chlamydia trachomatisMicrobiology, 1994
- Cytokine-regulated proteases in autoimmune diseasesImmunology Today, 1994
- TrachomaSeminars in Ophthalmology, 1993
- The matrix‐degrading metalloproteinasesBioEssays, 1992
- Purification and identification of 91‐kDa neutrophil gelatinaseEuropean Journal of Biochemistry, 1991
- Immunopathology of trachomatous conjunctivitis.British Journal of Ophthalmology, 1989